Company intelligence
Dipharma Francis S.r.l
Experience you can trust
About Dipharma Francis S.r.l
The Dipharma Group is a global CDMO and one of the leading family-owned manufacturers of Active Pharmaceutical Ingredients and Intermediates, having a portfolio of more than 40 products, with Drug Master Files lodged worldwide. Dipharma serves top ranking pharmaceutical companies in Europe, U.S.A. and Japan. Supported by a fully equipped R&D Centers, its core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenation, Chiral Synthesis, Organometallic Chemistry and Enzymatic Processes.
Verified activity
Signals from Dipharma Francis S.r.l
6 published signals
Partnerships
Dipharma Francis S.r.l. leverages AI and machine learning to support the development of more efficient, robust, and sustainable processes in the chemical-pharmaceutical industry.
Reported by Dipharma Francis S.r.l
Research & Knowledge
Dipharma Francis S.r.l. announced the development and implementation of a skid for testing continuous flow processes, including gas-liquid reactions, with a dedicated control system.
Reported by Dipharma Francis S.r.l
Research & Knowledge
Dipharma Francis S.r.l. developed and implemented an advanced skid for testing continuous flow processes, including gas-liquid reactions, equipped with a dedicated control system and data acquisition and processing capabilities.
Reported by Dipharma Francis S.r.l
People
Dipharma Francis S.r.l. spoke with Betsy Pierce, Project Manager at Dipharma Inc., about project management and CGMP manufacturing.
Reported by Dipharma Francis S.r.l
Presence & Recognition
Dipharma Francis S.r.l. is attending the CPHI Milan 2026 conference at Booth 12C1 from October 6 to 8 at Fiera Milano, Italy.
Reported by Dipharma Francis S.r.l
Presence & Recognition
Dipharma Francis S.r.l. is exhibiting at booth #99 in Boston for ChemOutsourcing 2026 from September 15 to 17.
Reported by Dipharma Francis S.r.l